Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital Plans to Commence Tender Offer to Repurchase up to $194 Million of Additional Shares

KROS

<p>同意回購 ADAR1 Capital Management 和 Pontifax Venture Capital 持有的所有股份，計劃開始要約回購最多 1.94 億美元的額外股份</p>

Keros Therapeutics 宣佈計劃返還 3.75 億美元的過剩資本